ReviewDiscover oncology2023

Progress and prospects in research and clinical practice of hormone receptor-positive, HER-2-negative breast cancer with BRCA1/2 mutations.

Shunchao Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.